Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: A multicenter study

Annals of Surgical Oncology

Volumn 18, Issue 6, 2011, Pages 1560-1567

  Chua, Terence C ^a   Morris, David L ^a   Saxena, Akshat ^a   Esquivel, Jesus ^c   Liauw, Winston ^b   Doerfer, Joerg ^d   Germer, Christoph Thomas ^d   Kerscher, Alexander G ^d   Pelz, Joerg O W ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c ST AGNES HOSPITAL   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PANITUMUMAB;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CAUSE OF DEATH; CLINICAL EVALUATION; COLORECTAL CARCINOMA; COLORECTAL PERITONEAL CARCINOMATOSIS; COLORECTAL SURGERY; CYTOREDUCTIVE SURGERY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY (TOPIC); OVERALL SURVIVAL; PATIENT SELECTION; PERIOPERATIVE PERIOD; PERITONEAL SURFACE DISEASE SEVERITY SCORE; PERITONEUM METASTASIS; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT SELECTION; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79956202441     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1522-1     Document Type: Article

References (15)

1. JS Tomlinson WR Jarnagin RP DeMatteo, et al. 2007 Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 4575 4580 17925551 10.1200/JCO.2007.11.0833 (Pubitemid 350035315)
2. M Rees PP Tekkis FK Welsh T O'Rourke TG John 2008 Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 125 135 18156932 10.1097/SLA.0b013e31815aa2c2
3. J Pfannschmidt H Dienemann H Hoffmann 2007 Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series Ann Thorac Surg 84 324 338 17588454 10.1016/j.athoracsur.2007.02.093 (Pubitemid 46921128)
4. D Elias F Gilly F Boutitie, et al. 2010 Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol 28 63 68 19917863 10.1200/JCO.2009.23.9285
5. O Glehen F Kwiatkowski PH Sugarbaker, et al. 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284 3292 15310771 10.1200/JCO.2004.10.012 1:STN:280: DC%2BD2cvgs1Giuw%3D%3D (Pubitemid 41103684)
6. VJ Verwaal S van Ruth E de Bree, et al. 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737 3743 14551293 10.1200/JCO.2003.04.187 (Pubitemid 46606227)
7. TC Chua A Saxena JF Schelleken, et al. 2010 Mortality and morbidity outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment Ann Surg 251 101 106 19838105 10.1097/SLA.0b013e3181b5ae43
8. OWP Joerg S Alexander N Aviram H Werner E Jesus 2009 Evaluation of a Peritoneal Surface Disease Severity Score in patients with colon cancer with peritoneal carcinomatosis J Surg Oncol 99 9 15 10.1002/jso.21169
9. TC Chua DL Morris J Esquivel 2010 Impact of the Peritoneal Surface Disease Severity Score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing a complete cytoreduction and hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 17 1330 1336 20033321 10.1245/s10434-009-0866-x
10. D Elias JH Lefevre J Chevalier, et al. 2009 Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 681 685 19103728 10.1200/JCO.2008.19.7160
11. VP Khatri 2010 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a panacea or just an obstacle course for the patient? J Clin Oncol 28 5 7 19917856 10.1200/JCO.2009.24.8500
12. J Franko Z Ibrahim NJ Gusani MP Holtzman DL Bartlett HJ Zeh 3rd 2010 Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus sytemic chemotherapy alone for colorectal peritoneal carcinomatosis Cancer 116 16 3756 62 20564081 10.1002/cncr.25116
13. YI Choi SH Lee BK Ahn, et al. 2008 Intestinal perforation in colorectal cancers treated with bevacizumab (Avastin) Cancer Res Treat 40 33 35 19688063 10.4143/crt.2008.40.1.33
14. TC Chua TD Yan A Saxena DL Morris 2009 Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality Ann Surg 249 900 907 19474692 10.1097/SLA.0b013e3181a45d86
15. TD Yan M Links S Fransi, et al. 2007 Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a nationally funded peritonectomy center Ann Surg Oncol 14 2270 2280 17464543 10.1245/s10434-007-9406-8 (Pubitemid 47174916)